Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qinghong Han

Showing results (51-60 of 143) with videos related to

Pageof 15
Sort By:
Anticancer Research|April 4, 2021
Oral-recombinant Methioninase Converts an Osteosarcoma from Docetaxel-resistant to -Sensitive in a Clinically-relevant Patient-derived Orthotopic-xenograft (PDOX) Mouse ModelYusuke Aoki, Yasunori Tome, Nathaniel F Wu, et al.
Anticancer Research|September 26, 2025
Recombinant Methioninase Selectively Eliminates Cancer Cells Co-cultured With Normal Fibroblasts Indicating the High-Precision Efficacy of Targeting Methionine Addiction of CancerByung Mo Kang, Qinghong Han, Shukuan Li, et al.
Cancer Genomics & Proteomics|April 17, 2022
Deletion of <i>MTAP</i> Highly Sensitizes Osteosarcoma Cells to Methionine Restriction With Recombinant MethioninaseYusuke Aoki, Yasunori Tome, Qinghong Han, et al.
Cancer Genomics & Proteomics|October 31, 2022
Oral Installation of Recombinant Methioninase-producing <i>Escherichia coli</i> into the Microbiome Inhibits Colon-cancer Growth in a Syngeneic Mouse ModelYutaro Kubota, Qinghong Han, Kazuyuki Hamada, et al.
Anticancer Research|January 30, 2022
Oral-recombinant Methioninase Converts an Osteosarcoma from Methotrexate-resistant to -sensitive in a Patient-derived Orthotopic-xenograft (PDOX) Mouse ModelYusuke Aoki, Yasunori Tome, Qinghong Han, et al.
Aging|June 10, 2023
Old-age-induced obesity reversed by a methionine-deficient diet or oral administration of recombinant methioninase-producing <i>Escherichia coli</i> in C57BL/6 miceYutaro Kubota, Qinghong Han, Jose Reynoso, et al.
Cancer Diagnosis & Prognosis|May 4, 2026
Chemotherapy in Combination With Methionine Restriction Induced A Complete Response in a Patient With Recurrent Metastatic Tongue Squamous-Cell CarcinomaTomoyuki Ishiguro, Toshihiko Sato, Qinghong Han, et al.
Cancer Diagnosis & Prognosis|January 5, 2026
Methionine Restriction Must Be Continuously Maintained to Selectively Inhibit Cancer Cells Co-cultured With Normal CellsByung Mo Kang, Qinghong Han, Shukuan Li, et al.
Anticancer Research|November 10, 2019
Combination of Trabectedin With Oxaliplatinum and 5-Fluorouracil Arrests a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse ModelGuangwei Zhu, Ming Zhao, Qinghong Han, et al.
Cancer Genomics & Proteomics|February 29, 2020
Pazopanib Inhibits Tumor Growth, Lymph-node Metastasis and Lymphangiogenesis of an Orthotopic Mouse of Colorectal CancerGuangwei Zhu, Ming Zhao, Qinghong Han, et al.
Pageof 15

Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Anticancer Research|April 4, 2021
Oral-recombinant Methioninase Converts an Osteosarcoma from Docetaxel-resistant to -Sensitive in a Clinically-relevant Patient-derived Orthotopic-xenograft (PDOX) Mouse ModelYusuke Aoki, Yasunori Tome, Nathaniel F Wu, et al.
Anticancer Research|September 26, 2025
Recombinant Methioninase Selectively Eliminates Cancer Cells Co-cultured With Normal Fibroblasts Indicating the High-Precision Efficacy of Targeting Methionine Addiction of CancerByung Mo Kang, Qinghong Han, Shukuan Li, et al.
Cancer Genomics & Proteomics|April 17, 2022
Deletion of <i>MTAP</i> Highly Sensitizes Osteosarcoma Cells to Methionine Restriction With Recombinant MethioninaseYusuke Aoki, Yasunori Tome, Qinghong Han, et al.
Cancer Genomics & Proteomics|October 31, 2022
Oral Installation of Recombinant Methioninase-producing <i>Escherichia coli</i> into the Microbiome Inhibits Colon-cancer Growth in a Syngeneic Mouse ModelYutaro Kubota, Qinghong Han, Kazuyuki Hamada, et al.
Anticancer Research|January 30, 2022
Oral-recombinant Methioninase Converts an Osteosarcoma from Methotrexate-resistant to -sensitive in a Patient-derived Orthotopic-xenograft (PDOX) Mouse ModelYusuke Aoki, Yasunori Tome, Qinghong Han, et al.
Aging|June 10, 2023
Old-age-induced obesity reversed by a methionine-deficient diet or oral administration of recombinant methioninase-producing <i>Escherichia coli</i> in C57BL/6 miceYutaro Kubota, Qinghong Han, Jose Reynoso, et al.
Cancer Diagnosis & Prognosis|May 4, 2026
Chemotherapy in Combination With Methionine Restriction Induced A Complete Response in a Patient With Recurrent Metastatic Tongue Squamous-Cell CarcinomaTomoyuki Ishiguro, Toshihiko Sato, Qinghong Han, et al.
Cancer Diagnosis & Prognosis|January 5, 2026
Methionine Restriction Must Be Continuously Maintained to Selectively Inhibit Cancer Cells Co-cultured With Normal CellsByung Mo Kang, Qinghong Han, Shukuan Li, et al.
Anticancer Research|November 10, 2019
Combination of Trabectedin With Oxaliplatinum and 5-Fluorouracil Arrests a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse ModelGuangwei Zhu, Ming Zhao, Qinghong Han, et al.
Cancer Genomics & Proteomics|February 29, 2020
Pazopanib Inhibits Tumor Growth, Lymph-node Metastasis and Lymphangiogenesis of an Orthotopic Mouse of Colorectal CancerGuangwei Zhu, Ming Zhao, Qinghong Han, et al.
Pageof 15